by Ashley Davis | Jun 13, 2019 | Press Releases
VeraSci, a leading provider of innovative scientific and technology services, announced today the hire of Hampton Corley, Chief Commercial Officer, to support growth objectives. As clinical trials grow in scope and complexity, VeraSci provides the scientific and...
by Ashley Davis | Jun 5, 2019 | Case Study
How VeraSci effectively and efficiently provided support to a large scale, multinational, long-term clinical trial for pre-clinical phase Alzheimer’s Disease.
by Ashley Davis | May 8, 2019 | Press Releases
VeraSci, a leading provider of innovative scientific and technology services, announced today that William P. Horan, PhD will join the company as Vice President of Clinical Science. In this role, Dr. Horan will use his expertise in cognition, clinical neuroscience,...
by Ashley Davis | Apr 29, 2019 | Blog
Recent findings from a National Multiple Sclerosis (MS) Study estimate that nearly 1 million people in the US are living with MS, a number that has more than doubled since it was last reported in 1975. We at VeraSci are committed to helping our clients drive therapies...
by Ashley Davis | Apr 9, 2019 | Press Releases
VeraSci recently welcomed Mark Skeen, MD as Senior Medical Scientist. In this role Dr. Skeen will provide disease state expertise for a broad range of neurologic diseases as well as the perspective of the clinician conducting clinical trials. As part of his role at...
